Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAA Clipping vs NOACs in Non-paroxysmal AF
NCT06021808Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Apr 2024
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoint: Rate of composite endpoint (Stroke, systemic embolism, all-cause mortality, major bleeding, clinically relevant non-major bleeding) at 24 months. Started Apr 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06021808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06021808.